48 results
8-K
MAIA
MAIA Biotechnology, Inc.
2 Apr 24
Departure of Directors or Certain Officers
4:10pm
Himmelreich dated August 30, 2023 (the “Himmelreich Employment Agreement”) was increased to $250,000 and the target Annual Bonus under Section 3
424B5
sftf0fu 9agtm
14 Feb 24
Prospectus supplement for primary offering
5:18pm
424B5
bcf xv96pziw
17 Nov 23
Prospectus supplement for primary offering
9:06am
8-K
bnkv3
15 Nov 23
Termination of a Material Definitive Agreement
8:42am
8-K
EX-10.1
tb15jl71xyygr3ztpusi
15 Nov 23
Termination of a Material Definitive Agreement
8:42am
8-K
EX-99.1
ead 26z5o8v6cqf3ge
8 Aug 23
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
DRS
lw87fefl
1 Jun 23
Draft registration statement
12:00am
8-K
EX-99.1
0t6r4tadbtor6y5xvi
8 May 23
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:15am
424B4
xnhkr5z
25 Apr 23
Prospectus supplement with pricing info
7:45pm
DEF 14A
l1i ucxa4yq
19 Apr 23
Definitive proxy
4:06pm